Declining use of brachytherapy for the treatment of prostate cancer

Brachytherapy

Volumn 13, Issue 2, 2014, Pages 157-162

  Mahmood, Usama ^a   Pugh, Thomas ^a   Frank, Steven ^a   Levy, Lawrence ^a   Walker, Gary ^a   Haque, Waqar ^a   Koshy, Matthew ^b   Graber, William ^a   Swanson, David ^a   Hoffman, Karen ^a   Kuban, Deborah ^a   Lee, Andrew ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Brachytherapy; Health expenditures; Prostatic neoplasms; Radiation; Utilization

Indexed keywords

BRACHYTHERAPY; HEALTH EXPENDITURES; PROSTATIC NEOPLASMS; RADIATION; UTILIZATION;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DATABASES, FACTUAL; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 84894103586     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2013.08.005     Document Type: Article

References (22)

1. National Comprehensive Cancer Network. Prostate Cancer V1. 2013. Available at. Accessed February 1,2013. http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.
2. Hamilton A.S., Albersten P.C., Johnson T.K., et al. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int 2011, 107:576-584.
3. Terakedis B.E., Rossi P.J., Liauw S.L., et al. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age. Am J Clin Oncol 2010, 33:619-623.
4. Jani A.B., Johnstone P.A., Liauw S.L., et al. Prostate cancer modality time trend analysis from 1973 to 2004: A Surveillance, Epidemiology, and End Results registry analysis. Am J Clin Oncol 2010, 33:168-172.
5. Copeland L.A., Elshaikh M.A., Jacksok J., et al. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma. Cancer 2005, 104:1372-1380.
6. Underwood W., Jackson J., Wei J.T., et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 2005, 103:538-545.
7. Perlroth D.J., Bhattacharya J., Godlman D.P., et al. An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr 2012, 45:250-257.
8. Sheets N.C., Goldin G.H., Meyer A.M., et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 2012, 307:1611-1620.
9. Nguyen P.L., Gu X., Lipsitz S.R., et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 2011, 29:1517-1524.
10. Surveillance, Epidemiology, and End Results (SEER): About SEER. National Cancer Institute. Available at. Accessed February 1,2013. http://www.seer.cancer.gov/about.
11. Walker G.V., Giordano S.H., Williams M., et al. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys 2013, 86:686-693.
12. Falit B.P., Gross C.P., Roberts K.B. Integrated prostate cancer centers and over-utilization of IMRT: A close look at fee-for-service medicine in radiation oncology. Int J Radiat Oncol Biol Phys 2010, 76:1285-1288.
13. Bekelman J.E., Suneja G., Guzzo T., et al. Effect of integration between urologists and radiation oncologists on prostate cancer treatment patterns. J Urol 2013, 190:97-101.
14. Carreyrou J, Tamman M. "A Device to Kill Cancer, Lift Revenue". The Wall Street Journal. December 7, 2010:1 [Print].
15. StatBite: Particle beam therapy facilities worldwide. J Natl Cancer Inst 2010, 102:450-453.
16. Zaorsky N.G., Studenski M.T., Dicker A.P., et al. Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?. Cancer Treat Rev 2013, 39:212-218.
17. Holloway C.L., Hsu I.-C.J., Albert M., et al. Prostate brachytherapy. Brachytherapy Applications and Techniques 2007, Lippincott Williams & Wilkins, Philadelphia, PA. P. Devlin (Ed.).
18. Bogdanich W. "At V.A. Hospital, a Rogue Cancer Unit". New York Times. June 20, 2009:1 [Print].
19. ACGME Program Requirements for Graduate Medical Education in Radiation Oncology. American Council for Graduate Medical Education. Available at. Accessed February 1,2013. http://www.acgme.org/acgmeweb/Portals/0/PFAssets/ProgramRequirements/430_radiation_oncology_01012009_f07012011.pdf.
20. Policy Regarding Brachytherapy Requirements. The American Board of Radiology. Available at. Accessed February 1,2013. http://www.theabr.org/the_abr/sites/all/themes/abr-media/pdf/Brachytherapy_Policy_2-21-2011%5B1%5D.pdf.
21. Gondi V., Bernard J.R., Jabbari S., et al. Results of the 2005-2008 Association of Residents in Radiation Oncology survey of chief residents in the United States: Clinical training and resident working conditions. Int J Radiat Oncol Biol Phys 2011, 81:1120-1127.
22. Buyyounouski M.K., Davis B.J., Prestidge B.R., et al. A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 Update. Brachytherapy 2012, 11:299-305.